Clinical study will use advanced MRI on breast cancer patients

A two-year clinical study is underway in which advanced imaging methods will be tested, with the hopes of providing valuable information, support and treatment to breast cancer patients and their physicians. The team will use MRI and analysis to make early predictions on how a specific patient’s tumor will eventually respond to therapy.

The clinical study is the first of its kind to focus primarily on cancer, and will be done through partnerships with Seton Healthcare Family, Texas Oncology and Austin Radiological Association and the University of Texas at Austin. The study is funded by the National Institutes of Health’s National Cancer Institute and the Cancer Prevention and Research Institute of Texas.

The study began Oct. 1 and the team plans to enroll 100 breast cancer patients from Seton and Texas Oncology. 

Read the full article below:

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.